Magle Chemoswed Holding AB (OSTO:MAGLE) Debt-to-Equity : 0.45 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB Debt-to-Equity?

Magle Chemoswed Holding AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr30.0 Mil. Magle Chemoswed Holding AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr41.9 Mil. Magle Chemoswed Holding AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr161.4 Mil. Magle Chemoswed Holding AB's debt to equity for the quarter that ended in Mar. 2024 was 0.45.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Magle Chemoswed Holding AB's Debt-to-Equity or its related term are showing as below:

OSTO:MAGLE' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.34 Max: 0.45
Current: 0.45

During the past 6 years, the highest Debt-to-Equity Ratio of Magle Chemoswed Holding AB was 0.45. The lowest was 0.04. And the median was 0.34.

OSTO:MAGLE's Debt-to-Equity is ranked worse than
73.13% of 1072 companies
in the Biotechnology industry
Industry Median: 0.14 vs OSTO:MAGLE: 0.45

Magle Chemoswed Holding AB Debt-to-Equity Historical Data

The historical data trend for Magle Chemoswed Holding AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB Debt-to-Equity Chart

Magle Chemoswed Holding AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.17

0.39

0.26

0.34

0.38

Magle Chemoswed Holding AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.40	0.35	0.37	0.38	0.45

Competitive Comparison of Magle Chemoswed Holding AB's Debt-to-Equity

For the Biotechnology subindustry, Magle Chemoswed Holding AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Magle Chemoswed Holding AB's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's Debt-to-Equity falls into.

Magle Chemoswed Holding AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Magle Chemoswed Holding AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(23.062	+	37.24)	/	158.225
	=	0.38

Magle Chemoswed Holding AB's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(30.014	+	41.877)	/	161.424
	=	0.45

Magle Chemoswed Holding AB (OSTO:MAGLE) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Magle Chemoswed Holding AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Agneslundsvagen 27, Malmo, SWE, 21215

Website

https://www.maglechemoswed.com

Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines